An early phase study to evaluate the efficacy and safety of AZD1419 in patients with asthma

Update Il y a 4 ans
Reference: EUCTR2016-000977-19

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the efficacy of inhaled AZD1419 in eosinophilic asthma patients after withdrawal of controller treatment of ICS + LABA, by evaluating Time to loss of asthma control


Inclusion criteria

  • AZD1419 is planned to be developed as a potential disease-modifying therapy for asthma. Target population is patients with moderate to severe eosinophilic asthma